| 申请日期 | 2026-01-12 | 申请号 | CA2252515 |
| 公开（公告）号 | CA2252515C | 公开（公告）日 | 2006-11-07 |
| 公开国别 | CA | 申请人省市代码 | 全国 |
| 申请人 | REYNOLDS TOBACCO CO R | ||
| 简介 | Patients susceptible to or suffering from central nervous system disorders a re treated by administering effective amounts of aryl substituted aliphatic amine compounds, aryl substituted olefinic amine compounds or aryl substituted acetylenic amine compounds. A representative compound is (E)-N-methyl-5-(3-pyridinyl)-4-penten-2-amine. | ||
|
您还没有登录，请登录后查看下载地址
|
客服热线：
手机版
二维码
